Education
About Us
Working with TipRanks
Follow Us
Greenrise Global Brands Inc (TSE:XCX)
:XCX
Top Page
Greenrise Global Brands Inc
(XCX)
Select Model
Select Model
Rating:23Underperform
Price Target:―
The overall stock score is significantly impacted by the company's critical financial condition, characterized by high leverage, negative equity, and cash flow problems. Technical analysis provides a slight positive offset with some short-term momentum, while valuation metrics reinforce concerns due to negative earnings and the lack of dividends.
Greenrise Global Brands Inc (XCX) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$258.28K
Dividend YieldN/A
Average Volume (3M)4.98K
Price to Earnings (P/E)―
Beta (1Y)-2.66
Revenue GrowthN/A
EPS Growth-368.52%
CountryCA
Employees200
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding51,655,370
10 Day Avg. Volume12,800
30 Day Avg. Volume4,983
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Greenrise Global Brands Inc Business Overview & Revenue Model
Company DescriptionGreenrise Global Brands Inc (XCX) is a company operating in the wellness and health sectors, focusing primarily on the development, distribution, and marketing of cannabis and hemp-derived products. The company is committed to providing high-quality, sustainable, and innovative products that cater to a wide range of consumer needs, including medicinal and recreational uses.
How the Company Makes MoneyGreenrise Global Brands Inc generates revenue primarily through the sale of its cannabis and hemp-based products. These products are sold through various channels, including direct-to-consumer sales, retail partnerships, and online platforms. The company may also engage in wholesale distribution to other businesses and maintain strategic partnerships with retailers and distributors to expand its market reach. Additional revenue streams can include licensing agreements for their proprietary strains or technologies. Collaboration with research institutions for product development can also contribute to its earnings, along with any ancillary services related to the cannabis industry.
Greenrise Global Brands Inc Financial Statement Overview
Summary
The company is facing severe financial difficulties with no revenue generation and significant losses. It is highly leveraged with negative equity, indicating potential insolvency risks. Cash flow issues are prominent, with consistently negative free cash flow.Income Statement
The company has shown no revenue in the TTM period and previous years, indicating severe challenges in generating sales. The net income remains negative, and the EBIT and EBITDA are also negative, reflecting operational inefficiencies and substantial losses.1
Very Negative
Balance Sheet
The balance sheet reflects a highly leveraged position with a negative stockholders' equity, indicating insolvency risk. The debt-to-equity ratio is extremely high, suggesting financial instability. Additionally, the company has negative equity, which is a significant red flag.5
Very Negative
Cash Flow
The company consistently generates negative free cash flow, which has deteriorated further in the TTM period. The operating cash flow is negative, and the free cash flow to net income ratio is undefined due to negative earnings, indicating liquidity issues and poor cash generation.10
Very Negative
| Breakdown | TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 452.87K | 105.20K | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 43.32K | -153.00 | 0.00 |
| EBITDA | -545.64K | 0.00 | -744.80K | -2.02M | -2.06M | 0.00 |
| Net Income | -725.85K | ― | -2.32M | -5.39M | -2.16M | -3.32M |
Balance Sheet | ||||||
| Total Assets | 93.53K | 441.82K | 1.25M | 252.94K | 371.56K | 547.98K |
| Cash, Cash Equivalents and Short-Term Investments | 13.53K | 31.53K | -619.68K | 27.45K | 60.45K | 242.86K |
| Total Debt | 2.62M | 2.80M | 3.15M | 1.90M | 1.08M | 366.53K |
| Total Liabilities | 2.79M | 3.06M | 3.56M | 2.26M | 1.34M | 639.12K |
| Stockholders Equity | -2.70M | -2.61M | -2.32M | -2.00M | -972.61K | ― |
Cash Flow | ||||||
| Free Cash Flow | -176.13K | 199.35K | -1.08M | -1.95M | -1.88M | ― |
| Operating Cash Flow | -176.13K | 199.35K | -1.08M | -1.89M | -1.83M | ― |
| Investing Cash Flow | 60.40K | 387.50K | -531.00K | -63.15K | 45.43K | 543.70K |
| Financing Cash Flow | 97.73K | -534.73K | 1.51M | 1.92M | 1.63M | 1.22M |
Greenrise Global Brands Inc Peers Comparison
Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | 317.01M | 78.67 | 2.02% | ― | 38.86% | ― | |
56 Neutral | 2.52B | -7.18 | -28.04% | ― | -2.64% | 1.65% | |
47 Neutral | 382.19M | -20.02 | -3.65% | ― | 28.42% | 48.33% | |
44 Neutral | 635.91M | -0.44 | -104.81% | ― | -4.24% | 55.82% | |
23 Underperform | C$258.28K | ― | 5.70% | ― | ― | -368.52% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
TSE:XCX
Greenrise Global Brands Inc
0.01
0.00
0.00%
TSE:LOWL
Lowell Farms
0.02
0.01
100.00%
AGFAF
Digicann Ventures
0.02
0.00
0.00%
PKBFF
PeakBirch Commerce
0.02
0.00
0.00%
LRSNF
Global Health Clinics
―
―
―
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.